1
|
Cohen ZR, Peshes-Yeloz N, Voll A, Zibly Z, Peer D. NT-09 * CO-DELIVERY OF siRNA AND CHEMOTHERAPY; A NEW APPROACH FOR GBM TREATMENT USING A NANOCARRIERS SYSTEM. Neuro Oncol 2014. [DOI: 10.1093/neuonc/nou265.9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
2
|
Bohn B, Scheuing N, Jehle PM, Laubner K, Born B, Merger S, Hummel M, Krakow D, Voll A, Zimmermann A, Zimny S, Holl RW. Are insulin analogues detemir or glulisine used preferentially in overweight/obese subjects? A German multicentre analysis of 38560 type 2 diabetic patients from the DPV registry. Exp Clin Endocrinol Diabetes 2014; 122:602-7. [PMID: 25054308 DOI: 10.1055/s-0034-1383646] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Abstract
OBJECTIVE Several studies suggest benefits of insulin analogues detemir or glulisine in overweight and obese patients with type 2 diabetes. The present multicentre study therefore examines, whether these insulin analogues are used more frequently in patients with increased body mass index. METHODS Data of 38 560 adult type 2 diabetic patients using insulin analogues, from 150 centres in Germany, registered in a standardized, prospective, computer-based documentation program (DPV), were included. Patients were classified into body mass index categories according to World Health Organization. Analysis was stratified by 3 time periods. To adjust for confounding effects, multivariable logistic regression models were created. RESULTS Detemir was preferentially used in overweight (OR 1.36, 95%-CI 1.20-1.53) and obese patients (OR 2.06, 95%-CI 1.84-2.31) compared to normal-weight patients. These effects remained significant after adjusting for sex, age, new/old federal state of Germany, size of centre, treatment in university clinic and clinic/specialized private practice. Models were additionally adjusted for time period and interaction of BMI category with age or sex. For glulisine, a minor effect was present when comparing obese to normal-weight patients (OR 1.26, 95%-CI 1.06-1.50). After adjustment, this finding was no longer significant. Stratified by obesity grade, class III obese patients more frequently used detemir or glulisine compared to class I obese patients. Comparing time periods, odds ratios did not differ, neither for detemir nor for glulisine. CONCLUSION Detemir is used more often in overweight and obese patients compared to normal-weight patients. For glulisine, the relationship is less pronounced.
Collapse
Affiliation(s)
- B Bohn
- Institute of Epidemiology and Medical Biometry, ZIBMT, University of Ulm, Ulm, Germany
| | - N Scheuing
- Institute of Epidemiology and Medical Biometry, ZIBMT, University of Ulm, Ulm, Germany
| | - P M Jehle
- Department of Internal Medicine, Academic Hospital Paul Gerhardt Stift, Lutherstadt Wittenberg, Martin- Luther-University Halle-Wittenberg, Germany
| | - K Laubner
- Division of Endocrinology and Diabetology, Department of Internal Medicine II, University Hospital of Freiburg, Freiburg, Germany
| | - B Born
- Department of Diabetology and Infectiology, Medical Clinic I, Reutlingen, Germany
| | - S Merger
- Division of Endocrinology, Diabetes and Metabolism, Graduate School of Molecular Diabetology and Endocrinology, Ulm University, Ulm, Germany
| | - M Hummel
- Specialized Diabetes Practice, Rosenheim, Germany
| | - D Krakow
- Diabetes Centre Forchheim, Germany
| | - A Voll
- Specialized Diabetes Practice, Traunstein, Germany
| | - A Zimmermann
- Specialized Diabetes Practice, Bad Aibling, Germany
| | - S Zimny
- Department for General Internal Medicine, Endocrinology and Diabetes, HELIOS Kliniken Schwerin, Schwerin, Germany
| | - R W Holl
- Institute of Epidemiology and Medical Biometry, ZIBMT, University of Ulm, Ulm, Germany
| | | |
Collapse
|
3
|
Hummel M, Best F, Voll A, Laubner K, Schöfl C, Scheuing N, Holl R. Gestationsdiabetes – Eine multizentrische Analyse von 9125 Patientinnen der multizentrischen DPV-Datenbank: Deskription und Veränderung über die letzten 14 Jahre. DIABETOL STOFFWECHS 2014. [DOI: 10.1055/s-0034-1374936] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
4
|
Awa WL, Fach E, Krakow D, Welp R, Kunder J, Voll A, Zeyfang A, Wagner C, Schütt M, Boehm B, de Souza M, Holl RW. Type 2 diabetes from pediatric to geriatric age: analysis of gender and obesity among 120,183 patients from the German/Austrian DPV database. Eur J Endocrinol 2012; 167:245-54. [PMID: 22645200 DOI: 10.1530/eje-12-0143] [Citation(s) in RCA: 47] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
AIM To characterize the clinical phenotype of type 2 diabetes mellitus (T2DM) with respect to age, gender, and BMI. METHOD Anonymized data of 120,183 people with T2DM from the German/Austrian multicenter Diabetes Patienten Verlaufsdokumentation database were analyzed based on chronological age or age at diagnosis (0-19, 20-39, 40-59, 60-79, and ≥80 years). Age, gender, and BMI comparisons with clinical phenotype were made using χ(2) and Kruskal-Wallis tests (SAS V9.2). RESULTS Of all the patients, 51.3% were male, average age was 67.112.7 years, and average disease duration was 9.99.1 years. More girls than boys were diagnosed during adolescence and more men than women during adulthood (2060 years). No gender differences existed when age at diagnosis was 60 years. Patients were obese on average (BMI: 30.5±6.1 kg/m(2)) and had significantly higher BMI values than German population peers. The BMI gap was widest in the younger age categories and closed with increasing age. Adult women were significantly more obese than men. Obese patients more often had elevated HbA1c (≥7.5%), hypertension or dyslipidemia (irrespective of age), microalbuminuria (adults), or retinopathy (elderly) than nonobese patients. More men than women (20-60 years) had hypertension, dyslipidemia, or microalbuminuria while more women than men (≥60 years) had hypertension or dyslipidemia. CONCLUSION During puberty, more girls than boys were diagnosed with T2DM while during adulthood males predominated. T2DM manifested at comparatively lower BMI in males, and younger patients were more obese at diagnosis. Age, gender, and BMI were also associated with poor metabolic control and cardiovascular disease comorbidities/complications.
Collapse
Affiliation(s)
- Wendy L Awa
- Institute of Epidemiology and Medical Biometry, University of Ulm, Albert-Einstein-Allee 41, 89081 Ulm, Germany
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
5
|
Voll A, Marquardt W. Reaction network flux analysis: Optimization-based evaluation of reaction pathways for biorenewables processing. AIChE J 2011. [DOI: 10.1002/aic.12704] [Citation(s) in RCA: 85] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
6
|
Schütt M, Kern W, Zimmermann A, Busch P, Kerner W, Voll A, Wagner C, Kann PH, Dapp A, Holl RW. Association of antidiabetic therapies to glycemic control and to body weight in type 2 diabetes: a German multicenter analysis on 9294 patients. Exp Clin Endocrinol Diabetes 2010; 118:490-5. [PMID: 20200811 DOI: 10.1055/s-0030-1249024] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
Abstract
Glycemic and body weight control are two outstanding goals in the treatment of patients with type 2 diabetes that often are not appropriately achieved. This observational study evaluates whether treatment by quality controlled diabetes centers generates an improvement in this regard and focuses on associations with different therapies. Data of 9.294 type 2 diabetic patients (mean age 66.9±11.6 years, mean diabetes duration 12.4±9.2 years) from 103 German diabetes centers were assessed by a standardized, prospective, computer-based diabetes care and outcome documentation system (DPV-Wiss-database). Therapeutic concepts included lifestyle intervention (n=1.813), oral antidiabetics (OAD, n=1.536), insulin (n=4.504) and insulin plus OAD (n=1.441). HbA1c and body weight were compared before and after a stable therapeutical period of 1.07±0.3 years. Change in HbA1c (%): all patients 7.4±1.6-7.0±1.3, lifestyle intervention 7.5±1.9-6.9±1.5, OAD 6.7±1.1-6.5±1.0, insulin 7.6±1.6-7.2±1.4, insulin plus OAD 7.5±1.5-7.2±1.3; each p≤0.05. Change in body weight (kg): all patients +0.08±0.07, n. s.; lifestyle intervention -0.28±0.20, OAD -0.56±0.13, each p<0.05 [metfomin -0.77±0.21, sulfonylurea drugs -0.75±0.34, each p<0.05; glitazones +0.62±0.70, α-glucosidase inhibitors -0.22±0.76, each n. s.], insulin +0.27±0.10, insulin plus OAD +0.63±0.14, each n. s. In summary, lifestyle, metformin or sulfonylurea drug treatment resulted in HbA1c-values below 7.0% plus a significant weight reduction. Insulin treatment-associated concepts resulted in HbA1c-values slightly above 7.0% without body weight alterations. These "real life" data underline that a specialised and quality controlled diabetes care is able to achieve significant treatment results even in patients with disease progression and a high proportion of insulin therapies.
Collapse
Affiliation(s)
- M Schütt
- Department of Internal Medicine I, University of Lübeck, Germany.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
7
|
Storstein O, Voll A. New prediction formulas for ventilatory measurements: A Study of Normal Individuals in the Age Group 20–59 Years. Scandinavian Journal of Clinical and Laboratory Investigation 2009. [DOI: 10.1080/00365516209051295] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
8
|
Abstract
BACKGROUND Individual variations in the course of Lewy body Parkinson disease (PD) are well known. Patients have been classified into different clinical subtypes to identify differences in the course among the subgroups. Several studies indicate that the outcome is more favorable in tremor dominant (TD) cases but others report no difference. A majority of progression studies are based on cross-sectional single point data or short-term clinical observations. The lack of longitudinally followed autopsy-confirmed PD cohort remains a major weakness in the literature. Biochemical studies of brain indicate most pronounced abnormalities in akinetic/rigid (AR) and the least in TD cases. We postulate that PD course in these subtypes is concordant with the biochemical findings. OBJECTIVE To compare the course in TD, mixed (MX), and AR subtypes of PD. METHODS Longitudinal clinical follow-up and autopsy studies were performed on 166 patients with PD over 39 years (1968-2006). Patients were classified into TD, AR, and MX based on the entire clinical course. Only the pathologically confirmed PD cases were included. RESULTS Sixty-six percent of cases had MX, 26% AR, and 8% TD profile. The age at onset was younger (p < 0.001) and progression to Hoehn & Yahr stage 4 was slower (p = 0.016) in the TD cases. Dementia was most common in AR (p = 0.039) and the least common in TD. In general, the course was most favorable in TD, followed by MX and AR subgroups. CONCLUSION The three subtypes of Parkinson disease have different courses which are concordant with the differences in brain biochemical abnormalities.
Collapse
Affiliation(s)
- A H Rajput
- Division of Neurology, Department of Pathology, Saskatoon Health Region/University of Saskatchewan, Canada
| | | | | | | | | |
Collapse
|
9
|
Schütt M, Kern W, Zimmermann A, Busch P, Kerner W, Voll A, Wagner C, Kann PH, Dapp A, Holl RW. Effekte verschiedener Diabetestherapien auf den Glucosestoffwechsel und auf das Körpergewicht – eine multizentrische Analyse von 9.294 Patienten mit Typ 2 Diabetes. DIABETOL STOFFWECHS 2009. [DOI: 10.1055/s-0029-1221940] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
10
|
Bartus B, Föhl A, Weidemeyer S, Herrmann M, Voll A, Zieher U, Kühnle A, Zezulak U. Veränderungen in der Lebensqualität und in der allgemeinen Ängstlichkeit bei Kindern und Jugendlichen mit Typ-1-Diabetes nach erlebnispädagogischen Ferienfreizeiten. DIABETOL STOFFWECHS 2008. [DOI: 10.1055/s-2008-1076312] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
11
|
Bartus B, Föhl A, Weidemeyer S, Herrmann M, Voll A, Zieher S, Kühnle A, Zezulak U. Können strukturierte Ferienfreizeiten für Kinder und Jugendliche mit Typ-1-Diabetes die Kenntnisse über die Behandlung verbessern und nachhaltig den Umgang mit dem Diabetes fördern? DIABETOL STOFFWECHS 2008. [DOI: 10.1055/s-2008-1076311] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
12
|
Schütt M, Kern W, Zimmermann A, Busch P, Kerner W, Voll A, Kann PH, Dapp A, Holl RW. Effekte verschiedener Diabetestherapien auf den Glucosestoffwechsel und auf das Körpergewicht – eine multizentrische Analyse von 4.353 Patienten mit Typ 2 Diabetes. DIABETOL STOFFWECHS 2007. [DOI: 10.1055/s-2007-982265] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
13
|
Rajput A, Voll A, Rajput M, Robinson C, Rajput A. 1.122 Course of akinetic/rigid and tremor dominant Parkinson's disease. Parkinsonism Relat Disord 2007. [DOI: 10.1016/s1353-8020(08)70393-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
14
|
Steup A, Metzner J, Voll A. [Simple photometric method for the determination of L-dopa and carbidopa in drug preparations]. Pharmazie 1986; 41:739. [PMID: 3823118] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
|
15
|
Voll A. Compendium der normalen Anatomie. Dtsch Med Wochenschr 1894. [DOI: 10.1055/s-0029-1205806] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|